The 20-HETE GPR75 axis has been implicated in cardiovascular, metabolic syndrome, and cancer through its vasoconstriction, insulin resistance, and proliferative properties (Pascale et al., 2023; Dashti et al., 2023; Murtaza et al., 2022). Here, GPR75 is linked to metabolic syndrome.